Meta-analysis of effect of nintedanib on mortality in subjects with idiopathic pulmonary fibrosis (IPF) and other forms of progressive pulmonary fibrosis ( PPF)

被引：0
作者：
Wuyts, Wim A. [1 ]
Maher, Toby M. [2 ]
Wijsenbeek, Marlies [3 ]
Koschel, Dirk [4 ]
Martinez, Fernando J. [5 ]
Stansen, Wibke [6 ]
Stowasser, Susanne [7 ]
Richeldi, Luca [8 ]
机构：
[1] Univ Hosp Leuven, Dept Pulm Med, Unit Interstitial Lung Dis, Leuven, Belgium
[2] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[3] Univ Med Ctr, Dept Resp Med, Erasmus MC, Rotterdam, Netherlands
[4] Fachkrankenhaus Coswig, Coswig, Germany
[5] Weill Cornell Med, New York, NY USA
[6] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany
[7] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[8] Univ Cattolica Sacro Cuore, Fdn Policlin Gemelli IRCCS, Rome, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA2875
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Nintedanib plus sildenafil in patients with idiopathic pulmonary fibrosis (IPF): the INSTAGE trial
    Kolb, Martin
    Wells, Athol
    Behr, Juergen
    Richeldi, Luca
    Schinzel, Birgit
    Quaresma, Manuel
    Stowasser, Susanne
    Raghu, Ganesh
    Martinez, Fernando J.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [32] Safety of Combined Pirfenidone and Nintedanib in Subgroups of Patients with Idiopathic Pulmonary Fibrosis (IPF)
    Flaherty, K.
    Fell, C. D.
    Huggins, J. T.
    Nunes, H.
    Sussman, R.
    Valenzuela, C.
    Petzinger, U.
    Stauffer, J. L.
    Gilberg, F.
    Bengus, M.
    Wijsenbeek, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [33] Role of nintedanib in the treatment of progressive pulmonary fibrosis (PPF) in daily clinical practice.
    Andres Franch, Fatima
    Alvarez Martinez, Ignacio Salvador
    Andujar Llamazares, Mario
    Segura Ayala, Daniel
    Meneses Petersen, Elsie Daviana
    Cabanes Lopez, Luis
    Novella Sanchez, Laura
    Ferrando Gabarda, Jose Ramon
    Meseguer Sisternes, Maria
    Lluch Tortajada, Inmaculada
    Naval Sendra, Elsa
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [34] Nintedanib in the treatment of idiopathic pulmonary fibrosis
    Mazzei, Mariano E.
    Richeldi, Luca
    Collard, Harold R.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2015, 9 (03) : 121 - 129
  • [35] Effect of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis Reply
    Costabel, Ulrich
    Stansen, Wibke
    Stowasser, Susanne
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (09) : 1275 - 1275
  • [36] Idiopathic Pulmonary Fibrosis (IPF): An Overview
    Barratt, Shaney L.
    Creamer, Andrew
    Hayton, Conal
    Chaudhuri, Nazia
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (08)
  • [37] Cost Analysis of Idiopathic Pulmonary Fibrosis: A Nintedanib Example
    Lebanova, Hristina
    Kirilov, Bogdan
    Grigorov, Evgeni
    Ninova, Vessela
    Getov, Ilko
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 142 - 143
  • [38] Sleep and idiopathic pulmonary fibrosis (IPF)
    Rasche, Kurt
    Leidag, Markus
    Orth, Maritta
    SOMNOLOGIE, 2020, 24 (01): : 11 - 15
  • [39] TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS (IPF)
    FULMER, J
    ELSON, N
    GAL, EV
    MCLEES, B
    DEMETS, D
    WEINBERGER, S
    KELMAN, J
    CRYSTAL, R
    CLINICAL RESEARCH, 1978, 26 (03): : A538 - A538
  • [40] Pirfenidone (PFD) effect on morbidity and mortality in patients with idiopathic pulmonary fibrosis (IPF)
    Noble, Paul W.
    Albera, Carlo
    Bradford, Williamson Z.
    Costabel, Ulrich
    du Bois, Roland M.
    Fishman, Robert S.
    Glaspole, Ian
    Glassberg, Marilyn K.
    Lancaster, Lisa
    Lederer, David
    Leff, Jonathan A.
    Nathan, Steven D.
    Pereira, Carlos A.
    Swigris, Jeffrey J.
    Valeyre, Dominique
    King, Talmadge E.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
12345